Crystal structure of chemically synthesized vMIP-II

Proteins: Structure, Function and Genetics

Volumn 67, Issue 1, 2007, Pages 243-246

  Li, Ying ^a   Liu, Dongxiang ^a   Cao, Rong ^a   Kumar, Santosh ^a   Dong, Changzhi ^a   An, Jing ^a,b   Wilson, Scott R ^a   Gao, Yi Gui ^a   Huang, Ziwei ^a,c  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b Chemokine Pharmaceutical Inc   (United States)

^c BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 2; UNCLASSIFIED DRUG; VIRUS MACROPHAGE INFLAMMATORY PROTEIN 2; VIRUS PROTEIN;

ARTICLE; BINDING AFFINITY; CRYSTAL STRUCTURE; HUMAN HERPESVIRUS 8; IMMUNE SYSTEM; LEUKOCYTE; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; CHEMOKINES; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT;

EID: 33847357308     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.21172     Document Type: Article

References (20)

1. Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore PS. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 1996;93:14862-14867.
2. Kledal TN, Rosenkilde MM, Coulin F, Simmons G, Johnsen AH, Alouani S, Power CA, Luttichau HR, Gerstoft J, Clapham PR, Clark-Lewis I, Wells TN, Schwartz TW. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science 1997;277:1656-1659.
3. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997;15:675-705.
4. Horuk R. Chemokine receptors. Cytokine Growth Factor Rev 2001;12:313-335.
5. Baldwin ET, Weber IT, St Charles R, Xuan JC, Appella E, Yamada M, Matsushima K, Edwards BF, Clore GM, Gronenborn AM, Wlodawer A. Crystal structure of interleukin 8: symbiosis of NMR and crystallography. Proc Natl Acad Sci USA 1991;88:502-506.
6. Kumar S, Choi WT, Madani N, Dong CZ, Tian S, Liu D, Fan X, Wang Y, Pesavento J, An J, Sodroski JG, Hunag Z. SMM-chemokines: a new class of unnatural synthetic molecules as chemical probes of chemokine receptor biology and lead for therapeutic development. Chem Biol 2006;13:69-79.
7. Fernandez EJ, Wilken J, Thompson DA, Peiper SC, Lolis E. Comparison of the structure of vMIP-II with eotaxin-1, RANTES, and MCP-3 suggests a unique mechanism for CCR3 activation. Biochemistry 2000;39:12837-12844.
8. Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 1997;276:307-326.
9. Navaza J. Amore-an Automated Package for Molecular Replacement. Acta Crystallogr Sect A 1994;50:157-163.
10. Brunger AT. X-PLOR Version 3.1: a system for X-ray crystallography and NMR. New Haven: Yale University Press; 1992.
11. Jones TA, Zou JY, Cowan SW, Kjeldgaard M. Improved methods for building protein models in electron-density maps and the location of errors in these models. Acta Crystallogr Sect A 1991;47:110-119.
12. Lubkowski J, Bujacz G, Boque L, Domaille PJ, Handel TM, Wlodawer A. The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions. Nat Struct Biol 1997;4:64-69.
13. Honig B, Nicholls A. Classical electrostatics in biology and chemistry. Science 1995;268:1144-1149.
14. Crump MP, Gong JH, Loetscher P, Rajarathnam K, Amara A, Arenzana-Seisdedos F, Virelizier JL, Baggiolini M, Sykes BD, Clark-Lewis I. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1 EMBO J 1997;16:6996-7007.
15. Lowman HB, Slagle PH, DeForge LE, Wirth CM, Gillece-Castro BL, Bourell JH, Fairbrother WJ. Exchanging interleukin-8 and melanoma growth-stimulating activity receptor binding specificities. J Biol Chem 1996;271:14344-14352.
16. Monteclaro FS, Charo IF. The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation. J Biol Chem 1996;271:19084-19092.
17. Wells TN, Power CA, Lusti-Narasimhan M, Hoogewerf AJ, Cooke RM, Chung CW, Peitsch MC, Proudfoot AE. Selectivity and antagonism of chemokine receptors. J Leukoc Biol 1996;59:53-60.
18. Gong W, Howard OM, Turpin JA, Grimm MC, Ueda H, Gray PW, Raport CJ, Oppenheim JJ, Wang JM. Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication. J Biol Chem 1998;273:4289-4292.
19. Bondue A, Jao SC, Blanpain C, Parmentier M, LiWang PJ. Characterization of the role of the N-loop of MIP-1β in CCR5 binding. Biochemistry 2002;41:13548-13555.
20. Pakianathan DR, Kuta EG, Artis DR, Skelton NJ, Hebert CA. Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3 and CCR5. Biochemistry 1997;36:9642-9648.